A focused evening bringing together leaders in translational medicine to explore opportunities at the intersection of aging and cancer. The event will convene scientists, clinicians, biotech innovators, investors, and healthcare stakeholders to discuss emerging research, translational pathways, and practical approaches to cancer prevention in the context of longevity. The program includes expert talks, an interactive Biotech Innovators in Aging and Cancer session, and the launch of the Cancer Prevention Institute Translational Hub, followed by a networking aperitif to foster collaboration and partnership.

PROGRAM

17:00: Welcome & Opening remarks
Pierre-Jean Wipff, Biopôle

17:05: Cancer prevention in the era of longevity
Prof. Gian-Paolo Dotto, Harvard Medical School

17:20: Cancer prevention in practice: Pilot studies in Switzerland
Dr. An Buckinx, CancerPrev Institute

17:35: Hormones: Keys to breast cancer prevention
Prof. Cathrin Brisken, EPFL

18:00: Biotech innovators in aging and cancer & roundtable
Skintegrity platform: Sabine Werner
EpiKare Bio: Gian-Paolo Dotto
Genknowme: Semira Gonseth Nusslé
Topadur Pharma: Matthias Schäfer
InnoMed Advisors: Nikolay Milev
Hedera Dx: Damien Lapray
Virdis Group: Nathalie Rowell
SIB: Vincent Zoete

19:00: Networking aperitif by Genknowme